Trials / Unknown
UnknownNCT02749656
Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) in the Treatment of Scalp Psoriasis
A Randomized Control Trial of Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) Compared With 0.25% Desoximetasone Cream (Topicorte®) in the Treatment of Scalp Psoriasis
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 105 (estimated)
- Sponsor
- Siriraj Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate efficacy and safety of 0.25% Desoximetasone cream (Topoxy®) compare with 0.25% Desoximetasone cream (Topicorte®) in the treatment of scalp psoriasis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 0.25% Desoximetasone cream (Topoxy®) | apply on the scalp psoriasis lesion twice a day |
| DRUG | 0.25% Desoximetasone cream (Topicorte®) | apply on the scalp psoriasis lesion twice a day |
| DRUG | Placebo | apply on the scalp psoriasis lesion twice a day |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2018-01-01
- Completion
- 2018-12-01
- First posted
- 2016-04-25
- Last updated
- 2017-05-01
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT02749656. Inclusion in this directory is not an endorsement.